Inventor
NGUYEN PHONG X
US42 patents
⚠️ This page may combine multiple inventors who share the name “NGUYEN PHONG X”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
23 patentsUS7091232B2Aug 15, 2006
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
ALLERGAN INC112 citations98
US7345077B2Mar 18, 2008
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
ALLERGAN INC12 citations92
US7323477B2Jan 29, 2008
7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline
ALLERGAN INC22 citations92
US7399868B2Jul 15, 2008
4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
ALLERGAN INC11 citations84
US7943641B2May 17, 2011
7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline
ALLERGAN INC7 citations83
US7419994B2Sep 2, 2008
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds
ALLERGAN INC8 citations73
US9572792B2Feb 21, 2017
Coumarin compounds as receptor modulators with therapeutic utility
ALLERGAN INC2 citations71
US9849113B2Dec 26, 2017
Methods of treating α adrenergic mediated conditions
ALLERGAN INC1 citations63
US9623006B2Apr 18, 2017
Methods of treating α adrenergic mediated conditions
ALLERGAN INC1 citations63
US8013169B2Sep 6, 2011
Naphthylmethylimidizoles as therapeutic agents
ALLERGAN INC2 citations63
US7868020B2Jan 11, 2011
Quinolynylmethylimidizoles as therapeutic agents
ALLERGAN INC2 citations63
US7683089B1Mar 23, 2010
4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
ALLERGAN INC4 citations63
US7396849B2Jul 8, 2008
4-(Condensed cyclicmethyl)-imidazole-2-thiones acting as α2 adrenergic agonists
ALLERGAN INC5 citations63
US8703745B1Apr 22, 2014
Compounds as receptor modulators with therapeutic utility
ALLERGAN INC0 citations52
US8703746B2Apr 22, 2014
Compounds as receptor modulators with therapeutic utility
ALLERGAN INC0 citations52
US8383646B2Feb 26, 2013
Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds
ALLERGAN INC0 citations52
US8362022B2Jan 29, 2013
Selective subtype alpha 2 adrenergic agents and methods for use thereof
ALLERGAN INC0 citations52
US7390829B2Jun 24, 2008
Alpha-2 adrenergic agonists
ALLERGAN INC1 citations52
US7795292B2Sep 14, 2010
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
ALLERGAN INC0 citations51
US8828973B2Sep 9, 2014
Compounds as receptor modulators with therapeutic utility
ALLERGAN INC1 citations50
US7838545B2Nov 23, 2010
4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
ALLERGAN INC0 citations50
US8741875B2Jun 3, 2014
Compounds as receptor modulators with therapeutic utility
ALLERGAN INC1 citations46
US8049037B2Nov 1, 2011
Sphingosine-1-phosphate (S1P) receptor antagonists and methods for use thereof
ALLERGAN INC0 citations42
HEIDELBAUGH TODD M
7 patentsUS8653270B2Feb 18, 2014
Compounds as receptor modulators with therapeutic utility
HEIDELBAUGH TODD M3 citations62
US9073888B2Jul 7, 2015
Coumarin compounds as receptor modulators with therapeutic utility
HEIDELBAUGH TODD M2 citations60
US8809379B2Aug 19, 2014
Selective subtype alpha 2 adrenergic agents and methods for use thereof
HEIDELBAUGH TODD M0 citations51
US8735399B2May 27, 2014
Selective subtype alpha 2 adrenergic agents and methods for use thereof
HEIDELBAUGH TODD M0 citations51
US8258167B2Sep 4, 2012
Naphthylmethylimidizoles as therapeutic agents
HEIDELBAUGH TODD M0 citations51
US8178571B2May 15, 2012
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
HEIDELBAUGH TODD M1 citations51
US8119807B2Feb 21, 2012
Quinolynylmethylimidizoles as therapeutic agents
HEIDELBAUGH TODD M0 citations51
NGUYEN PHONG X
5 patentsUS8329918B2Dec 11, 2012
Selective alpha 2B/2C agonists
NGUYEN PHONG X7 citations82
US8653062B2Feb 18, 2014
Compounds as receptor modulators with therapeutic utility
NGUYEN PHONG X1 citations61
US8486985B2Jul 16, 2013
Selective subtype alpha 2 adrenergic agents and methods for use thereof
NGUYEN PHONG X0 citations51
US8440644B2May 14, 2013
Compounds as receptor modulators with therapeutic utility
NGUYEN PHONG X0 citations51
US8168795B2May 1, 2012
Selective sphingosine-1-phosphate receptor antagonists
NGUYEN PHONG X0 citations40
CHOW KEN
3 patentsUS8063087B2Nov 22, 2011
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
CHOW KEN4 citations72
US8183414B2May 22, 2012
N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptors
CHOW KEN0 citations51
US8071635B2Dec 6, 2011
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazole-2-ones and related compounds
CHOW KEN0 citations51